Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man
- PMID: 833282
- PMCID: PMC333368
- DOI: 10.1172/JCI108649
Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man
Abstract
To investigate the role of glucagon in regulating hepatic glucose production in man, selective glucagon deficiency was produced in four normal men by infusing somatostatin (0.9 mg/h) and regular pork insulin (150-muU/kg per min) for 2 h. Exogenous glucose was infused to maintain euglycemia. Arterial plasma glucagon levels fell by greater than 50% whereas plasma insulin levels were maintained in the range of 10-14 muU/ml. In response to these hormonal changes, net splanchnic glucose production (NSGP) fell by 75% and remained suppressed for the duration of the study. In contrast, when somatostatin alone was administered to normal men, resulting in combined insulin and glucagon deficiency (euglycemia again maintained), NSGP fell markedly but only transiently, reaching its nadir at 15 min. Thereafter, NSGP rose progressively, reaching the basal rate at 105 min. These data indicate that the induction of selective glucagon deficiency in man (with basal insulin levels maintained) is associated with a marked and sustained fall in hepatic glucose production. We conclude, therefore, that basal glucagon plays an important role in the maintenance of basal hepatic glucose production in normal man.
Similar articles
-
The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.J Clin Invest. 1976 Dec;58(6):1407-18. doi: 10.1172/JCI108596. J Clin Invest. 1976. PMID: 993351 Free PMC article.
-
Control of hepatic glucose output by glucagon and insulin in the intact dog.Biochem Soc Symp. 1978;(43):31-45. Biochem Soc Symp. 1978. PMID: 373768 Review.
-
Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.J Clin Endocrinol Metab. 1979 Jan;48(1):171-5. doi: 10.1210/jcem-48-1-171. J Clin Endocrinol Metab. 1979. PMID: 422700
-
Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.J Clin Endocrinol Metab. 1977 Mar;44(3):474-80. doi: 10.1210/jcem-44-3-474. J Clin Endocrinol Metab. 1977. PMID: 838848
-
Glucagon and diabetes.Med Clin North Am. 1978 Jul;62(4):713-22. doi: 10.1016/s0025-7125(16)31767-9. Med Clin North Am. 1978. PMID: 355737 Review.
Cited by
-
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.J Clin Invest. 2012 Jan;122(1):4-12. doi: 10.1172/JCI60016. Epub 2012 Jan 3. J Clin Invest. 2012. PMID: 22214853 Free PMC article. Review.
-
Metabolic effects of glucagon in humans.J Clin Transl Endocrinol. 2018 Dec 20;15:45-53. doi: 10.1016/j.jcte.2018.12.005. eCollection 2019 Mar. J Clin Transl Endocrinol. 2018. PMID: 30619718 Free PMC article. Review.
-
Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons.FASEB J. 2019 Nov;33(11):11909-11924. doi: 10.1096/fj.201901315R. Epub 2019 Jul 31. FASEB J. 2019. PMID: 31366244 Free PMC article.
-
Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.Diabetologia. 1980 Mar;18(3):187-91. doi: 10.1007/BF00251914. Diabetologia. 1980. PMID: 6102941 No abstract available.
-
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.J Clin Invest. 1998 Mar 15;101(6):1203-9. doi: 10.1172/JCI579. J Clin Invest. 1998. PMID: 9502760 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
